Document Detail

Outcome of direct current cardioversion for atrial arrhythmias in adults with congenital heart disease.
MedLine Citation:
PMID:  20934227     Owner:  NLM     Status:  In-Data-Review    
OBJECTIVES: We sought to evaluate safety, efficacy, and outcome of direct current cardioversion (DCCV) for atrial arrhythmias in adults with congenital heart disease (CHD).
BACKGROUND: Atrial arrhythmias are increasingly noted in adults with CHD. The outcome of DCCV for atrial arrhythmias in this population is unknown.
METHODS: Our study was a retrospective review of patients 18years or older with CHD who underwent DCCV between June 2000 and July 2003. This constituted the CHD group. Patient characteristics reviewed included the specific cardiac diagnosis and arrhythmia history. A subset of patients had transesophageal echocardiography (TEE) before DCCV; this subset was reviewed to evaluate spontaneous echocardiographic contrast. The outcome data evaluated included success of DCCV, complications, recurrence of arrhythmia, antiarrhythmic medication use, electrophysiology or pacemaker procedure in follow-up, and all-cause mortality. The recurrence rate of the arrhythmia was compared to a control group consisting of an age, gender, and rhythm matched group of patients who have no CHD and who underwent DCCV for atrial arrhythmias.
RESULTS: Sixty-three patients in the CHD group underwent 80 DCCVs, 59 of which were TEE-guided. Atrial flutter was more common in the CHD group (37 of 80 DCCV, 46%) than in the control group (13 of 56, 23%) (p<0.001). DCCV was successful in 75 (94%). Mean follow-up was 387days. No thromboembolic events were noted. All-cause mortality on follow-up was 11%. There was no death related to DCCV. Twenty-five patients in the CHD group (40%) remained in sinus rhythm throughout follow-up. This was similar to that observed in the control group (30/56, 54%, p=0.13). Recurrent arrhythmia in the CHD group was predicted by the presence of atrial fibrillation (p=0.009) and less so spontaneous echo contrast in the left atrium (p=0.05).
CONCLUSIONS: DCCV with appropriate anticoagulation is safe and effective for patients with CHD, even in the presence of an intracardiac shunt and spontaneous contrast on TEE. However, the recurrence rate is substantial. Spontaneous echo contrast in the left atrium along with atrial fibrillation predicts arrhythmia recurrence following DCCV in patients with CHD.
Naser M Ammash; Sabrina D Phillips; David O Hodge; Heidi M Connolly; Martha A Grogan; Paul A Friedman; Carole A Warnes; Samuel J Asirvatham
Related Documents :
20484827 - Relationship between oral amiodarone and inappropriate therapy from an implantable card...
9408427 - Analysis of the treatment of spontaneous sustained stable ventricular tachycardia.
9116967 - Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard ...
20819537 - Nifekalant hydrochloride terminating sustained ventricular tachycardia accompanied with...
19483447 - A comparative study of early vs. delayed laparoscopic cholecystectomy in acute cholecys...
18398227 - Efficacy of a novel procedure sheath and closure device during diagnostic catheterizati...
Publication Detail:
Type:  Journal Article     Date:  2010-10-08
Journal Detail:
Title:  International journal of cardiology     Volume:  154     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-01-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  270-4     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Circumstances of death in adult congenital heart disease.
Next Document:  A rare case of right atrium mass involving the right coronary artery and the tricuspid annulus.